The use of capillary electrophoresis in the simultaneous determination of fixed-dose combination drugs for cardiovascular diseases

  • سال انتشار: 1399
  • محل انتشار: فصلنامه تحقیقات جاری در داروسازی، دوره: 6، شماره: 3
  • کد COI اختصاصی: JR_TIPS-6-3_008
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 169
دانلود فایل این مقاله

نویسندگان

Gabriel Hancu

University of Medicine, Pharmacy, Science and Technology George Emil Palade Targu Mureș

Daniela Tomegea

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Medicine, Pharmacy, Science and Technology of Targu Mureș

Gabriel Popescu

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Medicine, Pharmacy, Science and Technology of Targu Mureș

Eniko Barabas-Hajdu

Department of Cell biology and Microbiology, Faculty of Pharmacy, University of Medicine, Pharmacy, Science and Technology of Targu Mureș

چکیده

Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide and are usually multifactorial medical conditions. Usually cardiovascular patients must follow a complicated treatment scheme, containing several drugs. Fixed dose combinations (FDCs) are pharmaceutical formulations containing two or more active ingredients in a one pill. FDCs can add multiple benefits to the treatment of CVDs including increased patient compliance, elimination of some side effects and the simultaneous blockage of multiple pathogenic links. The great prevelance of FDCs in modern therapy brings the necessity of developing new analytical methods for the simultaneous analysis of their components. Capillary electrophoresis (CE) was shown to be as a complementary and attractive alternative to the more frequently used chromatographic methods. CE advantages relate to the high efficiency of separation, rapid method developement, short analysis time and relatively low operational costs. The most frequently used CE techniques in the analysis of FDCs are capilllary zone electrophoresis (CZE) for ionized analytes and micellar electrokinetic chromatography (MEKC) for neutral ones. The current article reviews application of CE in the analysis of FDCs used in the treatment of CVDs.

کلیدواژه ها

fixed dose combination, capillary electrophoresis, Cardiovascular diseases

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.